Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study - Bonanno, Silvia; Pasanisi, Maria Barbara; Frangiamore, Rita; Maggi, Lorenzo; Antozzi, Carlo; Andreetta, Francesca; Campanella, Angela; Brenna, Greta; Cottini, Lorenzo; Mantegazza, Renato (SAGE open medicine, 2018)
Keywords: Activities of daily living; Double-blind studies; Original; Quality of life; randomized clinical trial; Myasthenia gravis; MuSK; amifampridine